Cumberland Pharma launches chemo rescue drug Totect in U.S.

|About: Cumberland Pharmaceuti... (CPIX)|By:, SA News Editor

Cumberland Pharmaceuticals (CPIX +0.4%) and the Clinigen Group plc announce the commercial launch Totect (dexrazoxane hydrochloride) in the U.S. for the emergency intervention in case of extravasation in patients receiving anthracycline chemo.

Extravasation occurs when the injected chemo escapes from the blood vessels into the body where it can cause severe damage.

Clinigen acquired Totect in March 2016 to expand its dexrazoxane portfolio.

Subscribe for full text news in your inbox